Clinical Trial

Nurse-Led mHealth for Vulnerable-Phase Heart Failure

Completed
View on ClinicalTrials.gov →
Summary
Heart failure is a serious condition where the heart cannot pump blood as well as it should. After being discharged from the hospital, patients with heart failure are at high risk for readmission, especially in the first three months. This period is called the "vulnerable phase." Standard care often involves follow-up visits, but patients may struggle to manage their health at home. This study tested a new approach to care. The program is led by a nurse and uses a mobile health (mHealth) application on a smartphone. The app helps patients manage their health by providing daily medication reminders, tracking their weight and symptoms, and offering educational information. A team of doctors, pharmacists, and nurses work together to monitor patient data through the app. If any concerning signs appear, the team discusses the case and provides timely guidance to the patient. The study enrolled 100 patients with heart failure. Half of them received this nurse-led, app-based program in addition to their regular follow-up care. The other half received only the regular follow-up care. We measured how well patients managed their own care, how they felt (their symptoms), and key health indicators like heart function and a blood marker called NT-proBNP. We compared the two groups after three months.
Trial Details
NCT Number NCT07490470
Lead Sponsor Peking University First Hospital
Conditions Heart Failure
Enrollment 104 participants
Start Date 2022-06-01
Primary Completion 2024-06-27 (estimated)
Study Completion 2025-01-17 (estimated)
Updated on ClinicalTrials.gov 2026-03-24